SCHEMBL93262

SCHEMBL93262

CCCCCC(C)(C)O[C]=O

nearest known ligand 0.34

Predicted protein targets (top 6)

geneUniProtsupporting neighboursconfidence
FDPS P14324 11/20 0.34
GGPS1 O95749 7/20 0.34
SMPD1 P17405 5/20 0.34
CES2 O00748 1/20 0.32
LPAR1 Q92633 1/20 0.32
LPAR3 Q9UBY5 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2110792 0.98 GGPS1 (0.38) FDPSGGPS1SMPD1CES2LPAR1
SCHEMBL2111010 0.98 GGPS1 (0.38) FDPSGGPS1SMPD1CES2LPAR1
SCHEMBL2109067 0.98 GGPS1 (0.38) FDPSGGPS1SMPD1CES2LPAR1
SCHEMBL93145 0.98 GGPS1 (0.38) FDPSGGPS1SMPD1CES2LPAR1
SCHEMBL93197 0.98 GGPS1 (0.38) FDPSGGPS1SMPD1CES2LPAR1
SCHEMBL2107758 0.98 GGPS1 (0.38) FDPSGGPS1SMPD1CES2LPAR1
SCHEMBL2110487 0.98 GGPS1 (0.38) FDPSGGPS1SMPD1CES2LPAR1
SCHEMBL93231 0.93 FDPS (0.31) FDPS
SCHEMBL93253 0.83
SCHEMBL17374685 0.82 FDPS (0.34) FDPSGGPS1SMPD1CES2LPAR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 261 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-112209967-A Chiral spiro monophosphine-oxazoline ligand and preparation method thereof 瑞博(杭州)医药科技有限公司 2021-01-12 CN claimed
CN-111909206-A Chiral spiro monophosphine ligand and preparation method thereof 浙江瑞博制药有限公司 2020-11-10 CN claimed
US-20240239922-A1 PHOTOCURABLE COMPOSITION TOKYO OHKA KOGYO CO., LTD. (JP) 2024-07-18 US disclosed
US-12037531-B2 Photoresponsive high-molecular weight material, adhesive, toner, and image forming method Konica Minolta, Inc. (JP) 2024-07-16 US disclosed
US-12025909-B2 Photoresponsive compound Konica Minolta, Inc. (JP) 2024-07-02 US disclosed
US-20240192593-A1 PHOTOSENSITIVE COMPOSITION TOKYO OHKA KOGYO CO., LTD. (JP) 2024-06-13 US disclosed
US-20240191003-A1 COMPOSITION AND PHOTOSENSITIVE COMPOSITION TOKYO OHKA KOGYO CO., LTD. (JP) 2024-06-13 US disclosed
US-12006292-B2 Photoresponsive compound Konica Minolta, Inc. (JP) 2024-06-11 US disclosed
US-11994827-B2 Photoresponsive polymer Konica Minolta, Inc. (JP) 2024-05-28 US disclosed
US-11981794-B2 Curable composition, cured product, and compound TOKYO OHKA KOGYO CO., LTD. (JP) 2024-05-14 US disclosed
CN-117999296-A Composition and photosensitive composition 东京应化工业株式会社 2024-05-07 CN disclosed
US-4684603-A MAGENTA COUPLER, LIGHT FASTNESS KONISHIROKU PHOTO INDUSTRY CO., LTD. (JP) 1987-08-04 US disclosed
US-4675275-A COLORFAST MAGENTA COUPLERS KONISHIROKU PHOTO INDUSTRY CO., LTD. (JP) 1987-06-23 US disclosed
EP-0206461-A2 Silver halide photographic light-sensitive material KONICA CORPORATION (JP) 1986-12-30 EP disclosed
EP-0203746-A2 Light-sensitive silver halide photographic material KONICA CORPORATION (JP) 1986-12-03 EP disclosed
EP-0203465-A2 Light-sensitive silver halide photographic material KONICA CORPORATION (JP) 1986-12-03 EP disclosed
EP-0187521-A2 Light-sensitive silver halide photographic material KONICA CORPORATION (JP) 1986-07-16 EP disclosed
EP-0185506-A2 Light-sensitive silver halide photographic material KONICA CORPORATION (JP) 1986-06-25 EP disclosed
US-4540653-A METAL COMPLEX, ANILINO COUPLER KONISHIROKU PHOTO INDUSTRY CO., LTD. (JP) 1985-09-10 US disclosed
EP-0137271-A2 Method of improving the light resistance of a dye image KONICA CORPORATION (JP) 1985-04-17 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12006292-B2 Photoresponsive compound AFF1, CRY1, CRY2 FDPS 2277/4885GGPS1 2571/4885SMPD1 4594/4885
US-20240192593-A1 PHOTOSENSITIVE COMPOSITION PPOX, ERCC1, ERCC5 FDPS 355/4885GGPS1 110/4885SMPD1 3965/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.